NCT00904878Recruiting

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

University of California, San Francisco

Start Date

8/1/2007

Completion Date

6/1/2028

Summary

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.

Detailed Description

All pregnant women with IBD diagnosis who are taking biologics medicines and immunosuppressants will be entered in the study.

Eligibility Criteria

Age Range: 18 years to 45 years

Inclusion Criteria: * Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy Exclusion Criteria: * Pregnant female patients younger than 18 years of age * Confirmed multiple gestation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Inflammatory Bowel Disease

Locations

Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations

San Francisco, California 94115

United States

University of California San Francisco

San Francisco, California 94115

United States